Section Arrow
Quote
GENE.NASDAQ
- Genetic Technologies Ltd
Quotes are at least 15-min delayed:2024/05/20 14:55 EDT
Last
 2.32
+0.04 (+1.75%)
Day High 
2.34 
Prev. Close
2.28 
1-M High
3.2 
Volume 
7.91K 
Bid
2.26
Ask
2.35
Day Low
2.21 
Open
2.34 
1-M Low
2.1 
Market Cap 
10.05M 
Currency USD 
P/E -- 
%Yield 0 
10-SMA 2.35 
20-SMA 2.32 
50-SMA 2.6 
52-W High 5.9 
52-W Low 1.8 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.23/--
Enterprise Value
10.28M
Balance Sheet
Book Value Per Share
0.73
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
8.69M
Operating Revenue Per Share
1.30
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
DMTKDermTech0.3691-0.1304-26.11%-- 
EXASExact Sciences Corp51.3+0.92+1.83%-- 
GHGuardant Health24.94-0.42-1.66%-- 
OPKOPKO Health1.35+0.03+2.27%-- 
LABStandard BioTools2.59+0.02+0.78%-- 
Quotes are at least 15-min delayed：2024/05/20 14:55 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Genetic Technologies Ltd is an Australia-based molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. The company has developed BREVAGenplus which is a clinically validated risk assessment test for non-hereditary breast cancer. It also provides genetic testing services including medical testing, animal testing, forensic testing, and plant testing. The company markets BREVAGenplus to healthcare professionals in breast healthcare and imaging centers, as well as to obstetricians/ gynecologists (OBGYNs) and breast cancer risk assessment specialists. The majority of the company's revenue is generated from Australia and the United States. The group has two operating segments: EasyDNA and GeneType/Corporate.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.